Rentokil Initial PLC (RTO) Terminix Integration Case

• $RTO investors filed a lawsuit against Rentokil for misleading them about the success of its Terminix integration and the stability of its organic revenue growth in North America.

• Following a September 11, 2024, update revealing Terminix integration issues and lowered revenue growth, $RTO stock dropped by over 21%.

• $RTO investors can join this case to be notified about potential recovery.

Case Details:

Between December 2023 and September 2024, Rentokil frequently claimed that the integration of Terminix, acquired for $6.7 billion in 2022, was progressing smoothly.

The company emphasized “strong progress” and assured investors it was on track to achieve expected synergies and organic revenue growth of 2–4% for 2024.

However, in April 2024, Rentokil reported lower-than-expected North America organic growth of just 1.5% for Q1 2024.

By September 2024, Rentokil revealed in an unscheduled trading update that North America organic revenue growth for the second half of 2024 was expected to drop to just 1%.

Executives admitted to “self-inflicted” challenges with integrating Terminix, including disruptions and inefficiencies.

Following this, $RTO dropped over 21%.

Based on these events, $RTO investors filed a lawsuit against Rentokil, accusing the company of the following:

• It misled investors about the progress and success of the Terminix integration.

• It downplayed the challenges impacting organic revenue growth in North America.

Investors believe Rentokil misrepresented the state of the Terminix integration and its ability to deliver on growth targets.